Company Description
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally.
It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures.
The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds.
It also markets PACE systems that use acoustic pressure shockwaves generated by pulsed acoustic cellular expression technology to converge at selected areas for wound and orthopedic applications under the dermaPACE, Profile, and orthoPACE brand names.
The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota.
| Country | United States |
| Founded | 2004 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 46 |
| CEO | Morgan Frank |
Contact Details
Address: 11495 Valley View Road Eden Prairie, Minnesota 55344 United States | |
| Phone | 952 656 1029 |
| Website | sanuwave.com |
Stock Details
| Ticker Symbol | SNWV |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001417663 |
| CUSIP Number | 80303D107 |
| ISIN Number | US80303D3052 |
| Employer ID | 20-1176000 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Morgan C. Frank | Chief Executive Officer and Chairman |
| Peter Sorensen | Chief Financial Officer and Secretary |
| Daniel Coyle | Chief Operating Officer |
| Timothy Wern | Executive Vice President of Sales - U.S. Wound |
| Peter Stegagno | Chief Regulatory Officer |
| Dustin Libby | Executive Vice President of Commercial Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 7, 2025 | 8-K | Current Report |
| Nov 6, 2025 | 10-Q | Quarterly Report |
| Oct 30, 2025 | 8-K | Current Report |
| Oct 17, 2025 | SCHEDULE 13G | Filing |
| Oct 1, 2025 | 8-K | Current Report |
| Sep 26, 2025 | 8-K | Current Report |
| Aug 22, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Aug 21, 2025 | 8-K | Current Report |
| Aug 20, 2025 | 8-K | Current Report |
| Aug 14, 2025 | SCHEDULE 13G/A | Filing |